A comparison on effects of normalisations in the detection of differentially expressed genes by Chiogna, Monica et al.
BioMed  Central
Page 1 of 17
(page number not for citation purposes)
BMC Bioinformatics
Open Access Methodology article
A comparison on effects of normalisations in the detection of 
differentially expressed genes
Monica Chiogna1, Maria Sofia Massa1, Davide Risso2 and Chiara Romualdi*2
Address: 1Department of Statistical Sciences, University of Padova, via C. Battisti 241, 35121 Padova, Italy and 2CRIBI biotechnology Center, 
University of Padova, via U. Bassi 58/B, 35121 Padova, Italy
Email: Monica Chiogna - monica@stat.unipd.it; Maria Sofia Massa - massa@stat.unipd.it; Davide Risso - davide@stat.unipd.it; 
Chiara Romualdi* - chiara.romualdi@unipd.it
* Corresponding author    
Abstract
Background: Various normalisation techniques have been developed in the context of microarray
analysis to try to correct expression measurements for experimental bias and random fluctuations.
Major techniques include: total intensity normalisation; intensity dependent normalisation; and
variance stabilising normalisation. The aim of this paper is to discuss the impact of normalisation
techniques for two-channel array technology on the process of identification of differentially
expressed genes.
Results: Through three precise simulation plans, we quantify the impact of normalisations: (a) on
the sensitivity and specificity of a specified test statistic for the identification of deregulated genes,
(b) on the gene ranking induced by the statistic.
Conclusion: Although we found a limited difference of sensitivities and specificities for the test
after each normalisation, the study highlights a strong impact in terms of gene ranking agreement,
resulting in different levels of agreement between competing normalisations. However, we show
that the combination of two normalisations, such as glog and lowess, that handle different aspects
of microarray data, is able to outperform other individual techniques.
1 Background
Microarray technology is a powerful genomic approach
that enables researchers to quantify the expression levels
of large numbers of genes simultaneously in one single
experiment. Arrays can be single-channel (one-colour, cf.
Affymetrix technology), which quantify the absolute
expression of genes in specific experimental conditions, or
two channel (two-colour, cf. cDNA technology). A key
purpose of a two-colour microarray experiment is the
identification of genes which are differentially expressed
in two samples. Although this technology has given an
enormous scientific potential in the comprehension of
gene regulation processes, many sources of systematic var-
iation can affect the measured gene expression levels. The
purpose of data normalisation is to minimise the effects of
experimental and/or technical variations, so that mean-
ingful biological comparisons can be made and true bio-
logical changes can be found within one and among
multiple experiments. Several approaches have been pro-
posed and shown to be effective and beneficial in the
reduction of systematic errors within and between arrays,
both for single- and for double-channel technology [1-3].
Some authors proposed normalisation of the hybridisa-
tion intensities, while others preferred to normalise the
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intensity ratios. Some used global, linear methods, while
others used local, non-linear methods. Some suggested
using spike-in controls, or housekeeping genes, or invari-
ant genes, while others preferred all the genes on the array.
In general, microarray normalisation can be divided into
normalisation within arrays, for the correction of dye
effects, and across arrays, for the balance of the distribu-
tion differences among experiments. Several pre-process-
ing techniques recently proposed for two-channel
technology allow the joint normalisation within and
across experiments, as reported in the original papers ([4]
for the vsn/glog and [5] for the q-splines). Glog and q-
spline transformations, in fact, are performed on the gene
expression matrix where the two channels are considered
separately, allowing systematic bias reduction within and
across arrays. Although several normalisation procedures
have been proposed, it is still unclear which method uni-
formly outperforms the others under different experimen-
tal conditions. Recent works [6-8] compare, through
simulated data, normalisation methods in terms of bias,
variance, mean square error or leave-one-out cross-valida-
tion classification error. If we consider the two-channel
technology, Park et al. [7] show that, in some cases, inten-
sity dependent normalisation performs better than the
simpler global normalisation, while [3,9] raised the con-
cern that removal of spatial effects may add additional
noise to normalised data, suggesting that a safe alternative
is to remove the intensity effect only at a local level. Thus,
the evaluation of normalisation's effects in microarray
data analysis is still an important issue, since subsequent
analyses, such as tests for differential expression, could be
highly dependent on the choice of the normalisation pro-
cedure. For example, Durbin et al. [10] show that the log-
transformed expression ratio has a greatly inflated vari-
ance for expression values close to 0. This effect penalises
differential expression, especially for high expression lev-
els. Hypothesis tests for differential expression may in fact
be more effectively performed on data that have been
transformed so as to have constant variance. Hoffman and
colleagues [11] compare the effect of different normalisa-
tions on the identification of differentially expressed
genes within Affymetrix technology and using a real data-
set. They observe, by comparing lists of genes, that the
normalisation has a profound influence on the detection
of differentially expressed genes.
Moreover, the MicroArray Quality Control (MAQC) [12]
project, which is specifically designed to address repro-
ducibility of microarray technology by comparing results
obtained across different array platforms, chooses the sta-
tistical analysis on the base of the normalisation and gene
selection technique as the crucial steps in order to
improve reproducibility [13].
When microarray experiments are adopted with diagnos-
tic purposes, this result appears to be fundamental
because scientists are looking for a list of a few pathology
marker genes. Marker genes can be defined as genes whose
expression profiles are discriminating between case and
control samples. It is likely to suppose that the complete
list of markers of a condition is composed by hundreds of
genes, highly correlated and mostly implicated in few sig-
nalling cascades. Only few of them lie upstream these sig-
nalling cascades and are responsible of the differential
expression of all the others genes. Hence, if different pre-
processing have an impact on the identification of differ-
entially expressed genes, they could lead to different lists
of markers. The aim of this work is to compare and evalu-
ate the impact of various normalisation procedures pro-
posed for two-channel array technology on the
identification of marker genes. We shall use both simu-
lated and real data derived by cDNA and oligo microarray
(two-colour technique).
The use of a simulation approach allows us to study the
sensitivity and specificity of the tests after normalisation
and to compare different approaches' performances.
However, simulation of DNA microarray data can be
questioned, mainly because (i) the relation between
expression and experimental factors involved is not theo-
retically established, and (ii) the statistical distribution of
differential expression given by various causes across
genes is still controversial. In order to address such issues,
we adopt two different classes of simulation models.
Although we found a limited difference of sensitivities
and specificities for the tests after each normalisation, the
study highlights a strong impact in terms of gene ranking,
resulting in different levels of agreement between compet-
ing normalisations. Finally, we show that the combina-
tion of two normalisations, such as glog and lowess, that
handle different aspects of microarray data, is able to out-
perform the other individual techniques.
2 Results and Discussion
2.1 Simulated data
Figure 1 summarises our approach and Additional file 1
shows an example of MA plots obtained by our simula-
tion models. Additional file 3 and Figure 2 pictures results
from the GG and LNN simulation models (see Section
4.2.1); Additional file 2, Figure 3 and Figure 4 refer to
Albers' model (see Section 4.2.2), with different levels of
background (panel A and B: 10%, panel C and D: 50%,
panel E and F: 150%). As this last simulation model can
produce negative expression values, we investigate results
for both the cases in which negative values are replaced
(panels B, D, F of relevant figures) and kept as such (pan-
els A, C, E). This is because it is a common – but incorrect
– practice in microarray analysis to replace negative valuesBMC Bioinformatics 2009, 10:61 http://www.biomedcentral.com/1471-2105/10/61
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with arbitrarily small positive values, so that normalisa-
tions based on log expression ratios can still be employed.
To ease reading of the results, we performed the compari-
sons in two stages, involving: 1) q-splines, quantile,
enhanced quantile and enhanced q-spline, and 2) the best
normalisation obtained at step 1) with all the other tech-
niques.
We found that quantile and q-splines equally perform in
terms of specificity and sensitivity across all the simulated
scenarios both for GG/LNN models [data not shown] and
for Albers' model [Additional file 2]. On the contrary, sur-
prisingly, enhanced quantile and enhanced q-spline show
extremely reduced performances [Additional file 2]. We
deeply investigated this result. We found that, in all the
experimental scenarios, the additional steps performed by
the enhanced method after the quantile and q-spline nor-
malisation do not recover further relevant information
from the residual matrix (see Methods for more details).
Then, both with SAM and with EBayes test we observed a
strongly reduced FDR estimate that increases the number
of false positives genes and strongly reduces the test sensi-
tivity. In the light of these results, we decided to proceed
by taking into consideration in step 2 only q-splines nor-
malisations. In the following, step 2 results are reported.
In case of GG and LNN models without systematic bias
(Additional file 3 panels A, B) and of Albers' with 10% of
background level (Figure 3A, C), all the normalisations
show a similar performance. Global and glog normalisa-
tions seem to perform slightly worse than the others, but
using empirical confidence interval this difference is not
significant (data not shown). However, when a systematic
bias is included (Figure 2, panels A and B) and with
increasing background levels (Figure 3, panels C and E),
the normalisations respond differently. In particular, if we
consider Albers' model, q-spline and glog seem to increase
performance showing the best level of specificity and sen-
sitivity. This result can be explained by the presence of
Schema of the normalisations and analysis performed on the simulated data and real data Figure 1
Schema of the normalisations and analysis performed on the simulated data and real data.

	

	
	
	
	

	

	
 







 ! 



"


 



#$BMC Bioinformatics 2009, 10:61 http://www.biomedcentral.com/1471-2105/10/61
Page 4 of 17
(page number not for citation purposes)
LNN and GG models with non-linear bias Figure 2
LNN and GG models with non-linear bias. Specificity and sensitivity (panel A and B) and average overlapping rates with 
95% confidence interval of top ranking gene lists detected as differentially expressed between lowess and the others normalisa-
tions.
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negative values. Negative values in normalisations based
on log-ratio intensity transformation are necessarily
treated as missing (log transformation is not defined for
negative values). The replacement of negative values with
an arbitrarily known small value (Figure 3B, D and 3F)
has a general effect of slightly reducing specificity and sen-
sitivity after all normalisations. The major effect is evident
on the glog transformation that shows a dramatically
reduced sensitivity in case of 150% background level (Fig-
ure 3 panel F).
Differences among sensitivity and specificity of the nor-
malisations in Albers' simulated matrices have been quan-
tified through the area under the ROC curves (AUC).
Normalisations are ranked according to their AUC so that
the bigger the rank, the better the normalisation (Table 1).
To evaluate the reproducibility of our results and the
influence that the test statistic SAM had on the normalisa-
tions comparison, we re-calculated and compared ROC
curves using a different test statistic. ROC curves and the
ranking of normalisation obtained through AUC using
EBayes test are reported in Additional file 4 (panels A-F)
and Additional file 5, respectively. It is worth noting that
results obtained with the EBayes test are totally in agree-
ment with those obtained with SAM test.
Differences observed in normalisations performance is
evidently reflected in the gene ranking (Figure 2C, D and
Figure 4). We find that, on the first 100 genes, the highest
overlapping rate with the lowess list is around 80% with
values going down to 30% (Figure 4A, C and 4E, and
Additional file 6A, C and 6E). Agreement tends to reduce
even more when comparing gene lists with replaced neg-
ative values (Figure 4 panel B, D and F and Additional file
Specificity and sensitivity curves for Albers' model with increasing percentage of background level with respect to expression  level with and without replacing negative values Figure 3
Specificity and sensitivity curves for Albers' model with increasing percentage of background level with 
respect to expression level with and without replacing negative values. Panel A, C, E with 10%, 50% and 150%, 
respectively, background levels without negative values replacement; panel B, D and F with 10%, 50% and 150%, respectively, 
background levels with negative values replacement. See Simulation Plan Section for normalisation codes.
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Overlapping rates of top ranking gene lists detected as differentially expressed between lowess and the others normalisations Figure 4
Overlapping rates of top ranking gene lists detected as differentially expressed between lowess and the others 
normalisations. Panel A, C, E: results obtained from data generated by Albers' model with 10%, 50% and 150%, respectively, 
background levels without negative values replacement; panel B, D, F: results obtained from Albers' model with 10%, 50% and 
150%, respectively, background levels with negative values replacement.
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6B, D and 6F). These results have been confirmed using
EBayes test [Additional file 4 panels G-L].
In general, we observe that the OSLIN procedure is essen-
tially equivalent to OLIN, suggesting that the further scal-
ing factor introduced in OSLIN is redundant.
Lowess and OLIN tend to show similar performances,
which implies that the optimal estimate for the smooth-
ness parameter is usually close to the default one. How-
ever, in case of the well-known MA-plot "arrow head
effect", typical of an array characterised by a large propor-
tion of small constant values [Additional file 1 panel F]
the optimisation procedure erroneously captures an arrow
head effect trend, while lowess with smoothing parameter
set to the default value (0.4) ignores this trend.
The highly similar level of sensitivity and specificity of
most normalisations, jointly with a poor overlapping in
the gene lists, suggests that different pre-processing meth-
ods could be able of capturing alternative aspects of
microarray data, for example by identifying complemen-
tary lists of marker genes. Even if the identification of the
best normalisation procedure seems to be unfeasible, the
combination of different procedures could represent an
efficient alternative. Then, we evaluate the performance in
terms of specificity and sensitivity on simulated datasets
of glog and lowess normalisations in the following scenar-
ios: (i) the union of the gene lists obtained separately
from glog and lowess normalisations, (ii) the intersection
of the gene lists obtained separately from glog and lowess
normalisations, and (iii) the list obtained from the com-
bination of glog and lowess normalisations. This last sce-
nario should avoid missing negative values in case of a
high level of background and guarantee an efficient inten-
sity dependent normalisation. In addition, lowess nor-
malisation effectively removes biases within each slide
but does not account for differences across multiple
slides, which, on the contrary, are provided by glog. Spe-
cificity and sensitivity have been calculated by varying the
number of top ranking genes from 10 to 600 with step 20.
In case of scenarios (i) and (ii), the number of top ranking
genes in both lists have been selected in order to obtain a
union and intersection list of desired size. Figure 5 shows
the results either for GG, LNN or Albers' models. In simu-
lated datasets, the combination of glog and lowess proves
to be better than the other combinations. This result sug-
gests that combining these two normalisations is advanta-
geous in terms of identification of differentially expressed
genes.
2.2 Real data
Microarray normalisations are based on at least two fun-
damental assumptions: i) only a small portion of spots is
differentially expressed and ii) differentially expressed
spots are homogeneously distributed among the over and
the under expressed ones. These assumptions are reason-
able for most of large-scale genome experiments where
only a small proportion of the entire genome is involved
in the biological process studied, but could fail in case of
a platform with only limited genome coverage or for spe-
cific experimental treatments.
Therefore, we selected real datasets in order to consider
different experimental situations. We chose experiments
obtained with two spotted cDNA and two spotted oligos
platforms and characterised by i) a weak response in terms
of differential expression, ii) a strong response in terms of
differential expression, iii) a large number of negative val-
ues replaced, iv) a large number of negative values kept as
such. Table 2 briefly describes the datasets' characteristics.
Figure 6 shows the overlapping rates between normalisa-
tions for datasets A-D. In general, these results show a gen-
Table 1: Area Under the Curve (AUC) of specificity and sensitivity of SAM test after the normalisations, for Albers' model with 
increasing percentage of background level with and without replacing negative values.
10% bg 10% bg replaced 50% bg 50% bg replaced 150% bg 150% bg replaced
normalization AUC rank AUC rank AUC rank AUC rank AUC rank AUC rank
Raw 0.9 1 0.9 1 0.79 1 0.82 1 0.55 1 0.68 2
Global 0.91 2 0.91 2 0.84 2 0.86 2 0.66 2 0.74 4
GLOG 0.93 3 0.93 3 0.9 8 0.89 3 0.78 10 0.58 1
Lowess 0.94 6 0.93 3 0.86 3 0.9 6 0.69 6 0.73 3
P-Lowess 0.94 6 0.93 3 0.87 4 0.91 9 0.68 5 0.78 10
NeuralNet 0.93 3 0.93 3 0.87 4 0.91 9 0.69 6 0.76 5
OLIN 0.94 6 0.93 3 0.87 4 0.89 3 0.67 3 0.76 5
OSLIN 0.94 6 0.93 3 0.87 4 0.89 3 0.67 3 0.77 7
qsplineR N0.94 6 0.93 3 0.92 9 0.9 6 0.72 8 0.77 7
qsplineG 0.93 3 0.93 3 0.92 9 0.9 6 0.72 8 0.77 7
For each simulated scenario is also reported the ranking of the normalisations according to the AUC: the bigger the rank, the better the 
normalisation.BMC Bioinformatics 2009, 10:61 http://www.biomedcentral.com/1471-2105/10/61
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Specificity and sensitivity obtained after glog, lowess, combination of glog and lowess, union and intersection of lists of genes  obtained by glog and lowess performed separately Figure 5
Specificity and sensitivity obtained after glog, lowess, combination of glog and lowess, union and intersection 
of lists of genes obtained by glog and lowess performed separately. Panel A and B: GG and LNN models, respectively. 
Panel C, D, E: Albers' model with 10%, 50% and 150%, respectively, background levels without negative values replacement; 
panel F, G, H: Albers' model with 10%, 50% and 150%, respectively, background levels with negative values replacement.
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eral agreement with those obtained on simulated data.
Dataset B is characterised by the absence of negative val-
ues and a strong differential expression (rapamycin treat-
ment on Saccharomyces cerevisiae) symmetrical among up
and down regulation. The mean overlapping percentage is
about 70%. We note that normalisations on dataset B lead
to lists of genes with a higher overlapping rate with respect
to the others. On the other hand, datasets C and A are
characterised by the presence of negative spots and show
the worst overlapping percentage between glog and low-
ess. Through our simulation results we are able to differ-
entiate both situations. Replacement of negative values
(as in dataset A) has a negative effect on glog normalisa-
tion, dramatically decreasing specificity and sensitivity of
SAM test (Figure 3F), while the presence of negative values
kept as such (as in dataset C) negatively affects lowess-
type normalisations (Figure 3E). Thus, differences among
glog and lowess reflect i) the failure of glog to effectively
normalise dataset A and ii) the ability of glog to outper-
form the other normalisations in dataset C. The average
overlapping of dataset D is slightly less then 60%.
According to our results, differences among normalisation
performances seem to be independent from array plat-
forms and from the type of differential expression
response (under the condition that deregulation is sym-
metrically distributed among over and under expression)
but rather are dependent from the presence and the way
of dealing with negative values.
Performance of the combination of glog and lowess, as
well as of lowess and enhanced quantile, have been car-
ried out through the identification in dataset D of a small
list of true positives, retrieved from published biomedical
research literature by Bioinformatics Organization Inc.
Here, we include the combination of lowess and
enhanced quantile in order to evalute if the performance
of enhanced normalisation (poor in simulated data, see
Additional file 2) could be badly influenced by the Work-
man et al. [5] strategy used for two-channel technology.
The use of lowess and, then of enhanced quantile (on nor-
malised log ratio), should avoid this possibility. Table 3
shows the rank of true positive features obtained after
glog, lowess, union and intersection of gene lists obtained
from glog and lowess separately, the combination of glog
and lowess and the combination of lowess and enhanced
quantile. The smaller the rank of true positives, the more
efficient is the normalisation. The combination of glog
and lowess shows the smallest rank for most of the genes,
suggesting a better performance compared to the others
and confirming, even with real data, the poor perform-
ance of the combination of lowess and enahnced quan-
tile.
3 Conclusion
The main aim of this research effort was to report on an
exploratory study for benchmarking the impact of several
normalisation techniques in detecting differentially
expressed genes. The documentation of the simulation
models, the experimental setup, the analysis on real data
should enable the reader to assess the robustness and
scope of the benchmarking.
Results were presented in terms of mean sensitivities and
specificities and mean overlapping rates of gene ranking
lists. Summarising our results, we are able to say that, in
general, the comparison of the sensitivities and specifici-
ties shows limited difference in impact of preprocessing
over the range of operating conditions. On the other side,
the study highlights an evident impact in terms of gene
ranking agreement. With equal levels of specificity and
sensitivity, gene lists differ from an average of 40% of the
genes with Albers' model to an average of 20% with GG
and LNN models (with bias included).
This might have important effects on some microarray-
based research, where, through gene ranking and discri-
minant analysis, a small set of genes is selected to become
markers of the studied pathology. Our study suggests that,
putative marker genes obtained with different normalisa-
tions could be substantially different.
This is more evident in case of replacement of null or neg-
ative values where the higher the number of replacements,
Table 2: Description of real datasets used for the analyses.
Dataset Organism Platform Features Expected DEG Negative spots Replaced
A Baird et al. Homo sapiens cDNA 12,600 2,045 (0.16) 7,444 (0.59) With zero
B Urban et al. S. Cerevisiae Oligo 10,789 3,719 (0.34) None -
C Smith et al. S. Cerevisiae Oligo 25,240 27 (0.004) 524 (0.08) No
D De Pittà et al. Homo sapiens cDNA 9,984 1,353 (0.13) None -
For each dataset the table reports the organism, the platform, the number of features, the number of expected differentially expressed genes (DEG) 
(in brackets the expected proportion), the mean number of negative spots per array (in brackets the mean proportion), and if the negative spots 
are replaced or not. Note that in dataset C each array contains four replicates of each gene, giving a total of 6,130 unique features. Therefore, the 
proportion of genes expected to be differentially expressed has been calculated on the total of unique features. Expected number of DEG is 
calculated as the average number of differentially expressed genes obtained with SAM test after all the normalisations used in the study.BMC Bioinformatics 2009, 10:61 http://www.biomedcentral.com/1471-2105/10/61
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Overlapping rates of top ranking gene lists detected as differentially expressed between lowess and the others normalisations  in dataset A (panel A), dataset B (panel B), dataset C (panel C) and dataset D (panel D) Figure 6
Overlapping rates of top ranking gene lists detected as differentially expressed between lowess and the others 
normalisations in dataset A (panel A), dataset B (panel B), dataset C (panel C) and dataset D (panel D).
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the lower the sensitivity and specificity of the test, and the
lower the rate of agreement of gene ranking. Therefore,
the best pre-processing action might depend upon the dis-
tribution of the data, and a careful exploratory analysis is
called for before applying normalisation.
Real datasets (selected in order to cover different experi-
mental conditions) confirmed these results. Differences
among normalisation performances seem to be inde-
pendent from array platforms and from the type of differ-
ential expression response (under the condition that
deregulation is symmetrically distributed among over and
under expression), but seem to depend on the presence
and the handling of negative values. We also show that
the combination of glog and lowess may avoid the draw-
backs given by the negative values (due to highly level of
background) and may guarantee an efficient intensity
dependent normalisation. The advantage of the combina-
tion is much more evident without replacement of nega-
tive values.
4 Methods
4.1 Normalisation essentials
In this section, we give an overview of the essentials of the
normalisation techniques that are taken up in our com-
parative study. Since we are unable to cover all of the tech-
nical details in this article, we refer the reader to the
relevant literature.
Global normalisation
Global normalisation [1] is usually directed to balance the
different incorporation effciencies of the two fluoro-
phores (Cy3 dye and Cy5 dye) in the two-channel tech-
nology. Global intensity normalisation relies on the
assumption that the quantity of mRNA is the same for
both labelled samples. Furthermore, assuming a symmet-
rical distribution of over- and under-expressed genes for
thousands of genes in the array, these changes should bal-
ance out so that the total quantity of RNA hybridising to
the array from each sample is the same. Consequently, the
total integrated intensity for all spots should be the same
in both the Cy3 and Cy5 dyes. Under this assumption, a
normalisation factor can be calculated and used to re-scale
the intensity for each gene in the array.
Lowess normalisation and its variants
Lowess normalisation [14] relies on the use of a non-lin-
ear regression technique (the widely used LOWESS,
LOcally WEighted Scatterplot Smoothing) based on
robust local regression of the log ratios of Cy3/Cy5 on
overall spot intensity Cy3*Cy5 (the LOWESS smoother
for the so called MA-plots, where M is the log transforma-
tion of Cy3/Cy5 and A is the log transformation of the
squared root of Cy3*Cy5). The normalised M can be writ-
ten as
M' = M - c(A),
where c(·) is the LOWESS smoother. The normalisation
model is based on the assumption that a significant frac-
tion of the probes in the array is expressed at similar lev-
els.
Print-tip lowess normalisation (P-lowess hereafter) pro-
posed by Yang et al. [14] takes into account possible spa-
tial intensity artifacts introduced by robot print-tips
during the spotting step. P-lowess is based on individual
linear local regression (lowess) limited to a single print-
tip group. In this way, each print-tip group has its own
normalisation curve. The formula for the normalisation is
M' = M - ci(A),
where i = 1, ..., k is the i-th print-tip group.
Futschik and Crompton [15] show that the arbitrary use
of local regression parameters can severely compromise
the quality of normalised data. Parameter choice has com-
Table 3: Test statistic ranks of the 10 true positive genes obtained after glog, lowess, combination of glog and lowess, combination of 
lowess and enhanced quantile, union and intersection gene lists.
ID Symbol lower FC upper raw glog lowess glog+lowess lowess+enhancedQ
BL-003F10 PBX2 -2.02 -3.42 -4.83 130 474 158 26 179
BL-003F10 PBX2 -1.95 -3.36 -4.77 139 486 172 32 178
2-014C09 BTG1 -0.09 -1.94 -3.8 1080 7088 3302 741 556
BL-010C07 DLEU2 -0.99 -1.91 -2.83 275 902 529 163 613
BL-010C07 DLEU2 -0.81 -1.79 -2.77 375 955 538 184 624
2-025D04 CEBPA 2.51 1.53 0.54 527 1976 461 1462 2191
2-029B10 FUS -0.2 -1.51 -2.81 746 7268 543 855 1101
2-025D04 CEBPA 2.52 1.31 0.11 660 5228 1243 1678 677
2-029B10 FUS -0.41 -1.23 -2.05 685 1236 820 385 1421
2-019A01 CAV1 -0.05 -1.2 -2.34 1960 6519 1962 8034 1595
FC: fold change; upper and lower: confidence interval upper and lower bounds; Symbol: gene symbol.BMC Bioinformatics 2009, 10:61 http://www.biomedcentral.com/1471-2105/10/61
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monly been left to the user, and instructions on how to
adjust the parameters to the underlying data structure are
generally not given. In order to overcome these limita-
tions, Futschik and Crompton [16] introduce two normal-
isation schemes, Optimized Local Intensity-dependent
normalisation (OLIN) and Optimized Scaled Local Inten-
sity dependent normalisation (OSLIN), based on iterative
local regression and model selection. OLIN is based on
iterative local regression where parameters are optimised
in each regression step by generalised cross-validation.
OSLIN comprises OLIN procedure with a subsequent
optimised scaling of the range of log-intensity ratios
across the spatial array dimensions.
Neural Networks
Tarca and colleagues [17] propose a method based on a
robust neural network model that uses the log-intensity
ratio (M) as the independent variable, and the average
log-intensity (A) as well as spatial location of spots as pre-
dictors. Resistance to outliers is provided by assigning
weights to each spot based on how distant their M values
are from the median over the spots whose A values are
similar, and also by using pseudo-spatial coordinates
instead of spot row and column indices. The authors use
a simple feed-forward neural network with sigmoid acti-
vation function suggesting three neurons in the hidden
layer.
q-splines
Q-spline normalisation [5] uses the quantiles from each
array and the target to fit a system of cubic splines to nor-
malise the data. The target should be the (geometric)
mean or median of each probe. The authors propose
splines for their robustness in representing almost any
smooth relationship, including the linear one. Using
quantile information provides a much easier fitting prob-
lem and avoids fitting the pairwise data directly, which
often requires robust regression techniques.
Quantile
Originally, quantile normalisation [6] was proposed as an
across arrays normalisation suitable for single channel
technology. We decided to evaluate the quantile perform-
ance using the same strategy proposed by Workman et al.
[5] and Wu et al. [8] for the q-splines. The goal of quantile
normalisation is to give the same empirical distribution of
a target reference to each array. Following Wu et al. [8], the
reference target is defined as the geometric average of Cy3
(or Cy5) channel. Considering the simple case of dimen-
sion n = 2, if two data vectors have the same distribution,
a quantile-quantile plot will have a straight diagonal line,
with slope 1 and intercept 0. Thus, if the quantiles of two
data vectors are plotted against each other and each of
these points are projected onto the 45-degree diagonal
line, we obtained a transformation that gives the same dis-
tribution to both data vectors. Quantile normalisation is
the generalisation to n dimensions of the above transfor-
mation.
Enhanced procedure
The enhanced normalisation procedure recently proposed
by Hu and He [18] uses singular value decomposition
(SVDs) of the normalised microarray data matrix and of
the correspondent residual matrix (defined as the differ-
ence between the original matrix and the normalised one)
to allow users to filter out noise and recover relevant infor-
mation that might be lost in a given normalisation proce-
dure. The goal of the procedure is retaining maximal
relevant information in gene expression profiles. For an
exhaustive description of the methodology, see the origi-
nal paper by Hu and He [18]. In this study, we apply the
enhanced procedure to quantile and to q-spline normali-
sations.
Variance stabilising normalisation
As alternative to any other pre-processing technique,
Rocke and Durbin [19] and Huber and colleagues [4]
present independently a family of variance stabilising
transformations based on the generalised logarithmic
transformation (glog).
Glog assumes that raw gene expression intensities, y, can
be modeled as the sum of three components: (i) average
background noise, , (ii) true expression level, , multi-
plied by an exponential error term, , normally distrib-
uted with zero mean and variance  , and (iii) an
additive error term, , normally distributed with zero
mean and variance  , as
y =  + e + .
Glog transformation, which can be equivalently applied
to single- and double-channel microarray technology,
should achieve absence of relation between mean and var-
iance of the expression. It can be written as
with 
4.2 Simulation models
In this section, we document the simulation models that
we have used in our analyses.
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4.2.1 Hierarchical models
Generation of signal intensities
We adopt a mixture model strategy as in [20]. Genes come
from two different groups: differentially expressed (DE)
and equally expressed (EE). Each group is modelled by its
own distribution. The data as a whole are modelled by a
weighted mixture of these distributions, where the
weights p and (1 - p) correspond to the prior probabilities
of being differentially expressed and equally expressed,
respectively. If we write the expression value of the gene g
as ,  g = 1, ..., n, in the channel k, k = 1, 2, we have
According to the empirical Bayesian approach, we sup-
pose that the intensity values of the two channels   are
random samples from the distribution fobs (| g) with k
= 1, 2, respectively. In the EE case, we assume that the 2n
values are independent, identically distributed, according
to the distribution of fobs. Hence, under the EE hypothesis,
the marginal distribution is
where (g) is the prior distribution of the mean signal g,
representing variations in the mean intensity value of
genes in the experiment [20].
Under the DE hypothesis, the latent mean   of the
sample of the channel k is different in each k. In particular,
the two values of   are drawn independently from the
distribution (g), leading to
where
We considered the two mixture models of Kendziorski et
al. [20]. In the first model, named Gamma-Gamma (GG),
the intensities for the replicates in both conditions (Cy3
and Cy5) are assumed to be independently generated
from Gamma distributions with a constant shape param-
eter    and gene-specific random scales g, assumed to
have a Gamma distribution with shape hyperparameter
0 and scale hyperparameter . In the second model,
named lognormal-normal (LNN), the log intensities are
assumed to be normally distributed, with constant vari-
ance  2  and gene-specific random means g, that are
themselves normally distributed with hyperparameters 0
and . If a gene is selected to be equally expressed, then a
value for the random parameter is sampled from its prior
distribution, determining the distribution from which
independent replicates for both conditions are produced.
If a gene is selected to be differentially expressed, then two
values for the random parameter are sampled from its
prior distribution, determining the two distributions from
which independent replicates in each condition are pro-
duced.
Non-linear systematic bias
The hierarchical models GG and LNN simulate datasets
without intensity dependent systematic bias. Therefore,
any normalisation becomes redundant. For this reason,
we decided to introduce a systematic bias effect obtained
through the addition (to the log-ratio simulated by GG
and LNN models) of an opportunely scaled component,
inversely proportional to A.
4.2.2 Albers' additive model
Differently from the previous models, Albers et al. [21]
propose a model specifically drawn to include several lay-
ers of bias representative of possible experimental factors
influencing microarray experiments. Albers' model has 29
parameters, 6 of which are known constants, while the
others should be set by the user. The final log-expression
signals, ,  g = 1, ..., n, k = 1, 2, where n is the number of
genes in the platform and k is the channel index, are com-
posed by the following elements: (i) a gene expression
value,  , (ii) an expression change for differentially
expressed genes,  , (iii) a channel effect, Ck, (iv) a spot
pin effect, Sg, (v) a raw background gradient signal, bg, (vi)
a nonlinear effect, fnl, (vii) a fish-tail effect (inflating vari-
ance) due to the log transformation for small expression
values, td and (viii) a random error due to unknown fac-
tors, .  Then
and the error term is assumed to be Gaussian.
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4.3 Experimental setup
4.3.1 Hierarchical models
We fixed parameter values for GG and LNN models by
using estimates obtained on real datasets: for the GG
model, we set (, 0, ) = (3.6, 2.4, 1761.19) and for the
LNN model, we set (0, , ) = (7.9, 0.164, 0.895). Under
both models, the prior probability p of differential expres-
sion is set to 0.06.
4.3.2 Albers' model
Additional file 7 reports the parameters setup used in
Albers' model. Several of these values are proposed by the
authors as estimates obtained on real datasets. Three dif-
ferent background levels have been used. The maximum
of the background signal (%) relative to the non-back-
ground signal has been set to 10%, 50% and 150%. In this
way, different microarray data scenarios are obtained,
characterised by different proportions of negative expres-
sion values. In the first scenario (10%), expression values
are mostly positive; in the last one (150%), a large
number of negative values is observed. Albers' model
allows the inclusion of several types of systematic biases
(such as non-linear effect, fish-tail effect, background sur-
face variation).
4.3.3 Simulation Plan
For each model and set of parameters, we simulated 10
matrices with 10,000 genes expression levels on 15 exper-
iments separately for the Cy5 and Cy3 channels. So, each
simulated matrix consisted of 10,000 × 30 values (of
which 15 values are Cy5 levels and 15 Cy3 levels). Each of
the 10 matrices was pre-processed with 10 procedures,
coded as: raw data, global normalisation, lowess, P-low-
ess, OLIN, OSLIN, neural network, q-spline with target
Cy5 (called qsplineR) and q-spline with target Cy3 (called
qslineG), glog. GG and LNN models do not account for
print-tips platform geometry, therefore P-lowess normali-
sation was not considered in the comparison of perform-
ances of these models.
At the end of the pre-processing phase, we obtained 10
different matrices for each simulation. SAM analysis [22]
and empirical Bayes test [23] were performed on each
matrix. Figure 1 summarises the entire simulation plan.
To compute the average overlapping rates, we considered
the following values for the length of the top ranking gene
lists: 20, 50, 100, 500, and 600.
4.3.4 Real Data
We used two cDNA expression datasets and two oligonu-
cleotide datasets to validate our simulation results. All the
datasets are publicly available at the GEO database.
Baird et al. [24] (hereafter dataset A) studied expression
profiling of 181 tumors representing various classes of
bone and soft tissue sarcomas. In this study, we selected
only the 18 Ewing's sarcoma samples. The common refer-
ence was obtained by pooling sarcoma cell lines. Expres-
sion datasets and platform annotation are available on
the NCBI GEO database with platform identification
number GPL1977 and reference series GSE2553.
Urban et al. [25] (hereafter dataset B) analysed the
rapamycin response in Saccharomyces cerevisiae. Global
transcriptional analysis of rapamycin response was con-
ducted on cells expressing either a wild-type or TOR-inde-
pendent allele of Sch9. In our work, we considered only
samples GSM185035, GSM185498, GSM185503,
GSM185504, GSM185518, GSM185519. Expression
datasets and platform annotation are available on the
NCBI GEO database with platform identification number
GPL884 and reference series GSE7660.
Smith et al. [26] (hereafter dataset C) studied the expres-
sion profiles of transcription factor deletion strains in the
presence of oleate. mRNA levels in each of four deletion
strains (delta_OAF1, delta_PIP2, delta_ADR1 or
delta_OAF3) were compared to those in wild type cells by
microarray analysis. There were two biological replicates
for each experiment, and for each replicate both label ori-
entations were analysed on arrays containing 4 replicate
spots of each gene, resulting in a total of 16 replicate spots
per gene. For our study we considered only the
delta_ADR1 samples. Expression datasets and platform
annotation are available on the NCBI GEO database with
platform identification number GPL4287 and GPL4303,
and reference series GSE5862.
De Pittà and colleagues [27] (hereafter dataset D)
obtained expression profiling of bone marrow from pae-
diatric patients with acute lymphoblastic leukemia (ALL)
using a dedicated muscle cDNA array. Patients were clini-
cally classified into B-cell ALL (9 samples), T-cell ALL (5
samples) and all compared to a common reference (com-
mercial RNA, Stratagene, Europe) prepared from male
fetal skeletal muscle. Expression datasets and platform
annotation are available on the NCBI GEO database with
platform identification number GPL2011 and reference
series GSE2604.
By the analysis of four datasets, we are able to test the nor-
malisation procedures in different situations: (i) either a
large (dataset B) or a small (dataset C) proportion of
genes expected to be differentially expressed; (ii) either
cDNA (dataset A and D) or oligonucleotide (dataset B and
C) microarrays; (iii) microarrays with a large number of
negative spots, either replaced with zero (dataset A) or
kept as such (dataset C). See Table 2 for a description ofBMC Bioinformatics 2009, 10:61 http://www.biomedcentral.com/1471-2105/10/61
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each dataset. Due to the large amount of negative spots
per array, we considered for the dataset A only 6,154 genes
(6,446 genes were filtered because of the presence of more
than 80% of missing values on the total number of exper-
iments).
From published biomedical research literature, Bioinfor-
matics Organization Inc. retrieved a list of 70 genes exper-
imentally known to be deregulated in acute
lymphoblastic leukemia, and stored them in a public
database available at https://www.bioinformatics.org/leg
end/legend.htm. Of these 70 genes, only 36 were present
in the custom array used by De Pittà et al. [27], among
which 10 were found significantly deregulated. Therefore,
in dataset A these 10 genes were considered as true posi-
tives, in order to evaluate the performance of some nor-
malisations.
4.3.5 Evaluation criteria
To evaluate the impact of the normalisation techniques in
detecting differentially expressed genes in simulated data-
sets, we compare the results of a significance analysis
based on SAM and empirical Bayes test statistic after vari-
ous normalisations.
SAM test
SAM test statistic dg is defined as [22]:
where sg is the standard deviation and s0 is a positive cos-
tant, usually the 90th percentile of the sg distribution. Val-
ues and significance of the SAM statistic is obtained via a
permutational approach [22] as follows.
1. Calculate the observed values
for any g = 1, ..., p.
2. Order the observed values
d(1)  d(2)  ...  d(p).
3. For any permutation k (with k = 1, ..., K) of data calcu-
late
4. Order the values dg(k)
d(1)(k)  d(2)(k)  ...  d(p)(k).
5. Define the mean quantity
To identify differentially expressed genes, the observed
values d(g) and d(g)(E) are compared and a threshold  is
defined such that the gene g  is called differentially
expressed if |dg - dg(E)| > .
Empirical Bayes test
The empiricial Bayes test (EBayes hereafter) [23] is based
on a moderated t-statistic with a Bayesian adjusted
denominator similar to that proposed by Tusher et al.
[22]. EBayes uses a hybrid Bayes approach in which gene
variances are modelled by a prior distribution that is
updated using the data to obtain posterior distribution.
Then, an estimate is derived from the posterior distribu-
tion. This shrinks the observed variances towards the prior
mean. Given a prior estimate p of the proportion of differ-
entially expressed genes, the posterior probability that a
gene is differentially expressed can be calculated. The B-
statistic given by Limma is the log-odd of being differen-
tially expressed versus equally expressed. We calculated
the adjusted p-values with Benjamini and Hochberg [28]
procedure in order to rank the genes; the lower the p-
value, the more significant the result.
Performance evaluation
In our analyses, the significance analysis is used to con-
struct sensitivity (true-positive rate) and specificity (1 -
false-positive rate) for the test. For various thresholds (of
 parameter for SAM and of adjusted p-value for EBayes),
we identify the significant genes and compute the corre-
sponding average sensitivity and specificity of the test.
Agreement among the impacts of different normalisations
is also evaluated by looking at the ranking induced on the
genes by the absolute value of both statistics. Genes are
ordered according to the absolute value of each statistic
from the highest (rank 1) to the lowest (rank n, where n is
the total number of genes). Then, genes to which corre-
spond rank less than or equal to 20, 50, 100, 500 and 600
are compared across normalisations. Taking as reference
lowess normalisation, the mean rate of common genes
(overlapping rate) in the two top ranking gene lists (the
list obtained after the lowess procedure versus all the oth-
ers) has been calculated for various lengths of the list.
Since on real datasets true positives are generally
unknown, the procedures' agreement has been evaluated
through the average overlapping rates in the top ranking
gene lists. However, for dataset D a small list of true posi-
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tive genes was available, therefore the ranks of the true
positives were used to evaluate the performance of nor-
malisations. Further, we note that, the smaller the rank,
the more efficient is the normalisation.
All statistical analysises have been performed with the R
statistical package freely available on http://www.r-
project.org/. Packages used: Biobase, Ebarrays, marray,
samr, vsn, OLIN, nnNORM, affy, limma.
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